MedTrace Logo

Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After Laparoscopy

NCT05246631 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-02-18

No results posted yet for this study

Summary

This study aim to find out the effectiveness of 1 mg intravenous haloperidol compared to 5 mg intravenous dexamethasone to prevent the occurrence of nausea and vomiting also as pain control in adult patients after laparoscopic surgery.

Conditions

  • Laparoscopy
  • Postoperative Nausea and Vomiting

Interventions

DRUG

Dexamethasone injection

Group A consisted of patients given 5 mg intravenous dexamethasone after induction.

DRUG

Haloperidol Injection

Group B consisted of patients given 1 mg intravenous haloperidol one hour before the surgery ended

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Aldy Heriwardito, Doctor · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-03-30
Completion
2020-07-30
FDA Drug
Yes

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05246631 on ClinicalTrials.gov